510(k) K760077
K760077 is an FDA 510(k) premarket notification submitted by Smithkline Diagnostics, Inc. for the device "TEST, RIA, SERUM DIGOXIN". The FDA issued a decision of Substantially Equivalent on July 16, 1976. The device falls under product code DND (Radioimmunoassay, Digitoxin (125-I), Rabbit Antibody, Solid Phase Sep.), a Class II device regulated under 21 CFR 862.3300. Smithkline Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 16, 1976
- Date Received
- June 18, 1976
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Digitoxin (125-I), Rabbit Antibody, Solid Phase Sep.
- Device Class
- Class II
- Regulation Number
- 862.3300
- Review Panel
- TX
- Submission Type